Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;73(7):1244-1252.
doi: 10.1002/art.41637. Epub 2021 May 18.

Genetic Association of a Gain-of-Function IFNGR1 Polymorphism and the Intergenic Region LNCAROD/DKK1 With Behçet's Disease

Affiliations

Genetic Association of a Gain-of-Function IFNGR1 Polymorphism and the Intergenic Region LNCAROD/DKK1 With Behçet's Disease

Lourdes Ortiz Fernández et al. Arthritis Rheumatol. 2021 Jul.

Abstract

Objective: Behçet's disease is a complex systemic inflammatory vasculitis of incompletely understood etiology. This study was undertaken to investigate genetic associations with Behçet's disease in a diverse multiethnic population.

Methods: A total of 9,444 patients and controls from 7 different populations were included in this study. Genotyping was performed using an Infinium ImmunoArray-24 v.1.0 or v.2.0 BeadChip. Analysis of expression data from stimulated monocytes, and epigenetic and chromatin interaction analyses were performed.

Results: We identified 2 novel genetic susceptibility loci for Behçet's disease, including a risk locus in IFNGR1 (rs4896243) (odds ratio [OR] 1.25; P = 2.42 × 10-9 ) and within the intergenic region LNCAROD/DKK1 (rs1660760) (OR 0.78; P = 2.75 × 10-8 ). The risk variants in IFNGR1 significantly increased IFNGR1 messenger RNA expression in lipopolysaccharide-stimulated monocytes. In addition, our results replicated the association (P < 5 × 10-8 ) of 6 previously identified susceptibility loci in Behçet's disease: IL10, IL23R, IL12A-AS1, CCR3, ADO, and LACC1, reinforcing the notion that these loci are strong genetic factors in Behçet's disease shared across ancestries. We also identified >30 genetic susceptibility loci with a suggestive level of association (P < 5 × 10-5 ), which will require replication. Finally, functional annotation of genetic susceptibility loci in Behçet's disease revealed their possible regulatory roles and suggested potential causal genes and molecular mechanisms that could be further investigated.

Conclusion: We performed the largest genetic association study in Behçet's disease to date. Our findings reveal novel putative functional variants associated with the disease and replicate and extend the genetic associations in other loci across multiple ancestries.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors have declared that no conflict of interest exists

Figures

Figure 1.
Figure 1.. Manhattan plot showing the results of a meta-analysis of Behçet’s disease cases and controls included in this study.
The -log10 p value for each genetic variant analyzed is plotted against its physical chromosomal position. The red and blue lines represent the genome-wide level of significance (p value < 5 × 10−8) and the suggestive level of significance (p value < 5 × 10−5), respectively.
Figure 2.
Figure 2.. Expression quantitative trait loci (eQTL) associations between two IFNGR1-variants (rs1327474 and rs4896243) and IFNGR1 transcript in 2-hour lipopolysaccharide (LPS) stimulated monocytes.
The risk alleles (C) for both SNPs correlate with significantly higher expression levels of IFNGR1 (one-way ANOVA p value= 1.08 × 10−4 and 8.25 × 10−5, respectively). Differences between genotypes were assessed using Tukey’s multiple comparisons test; rs1327474 (CC vs. CT, p = 4.40 × 10−2; CC vs. TT, p = 5.98 × 10−5; CT vs. TT = 2.10 × 10−2), rs4896243 (CC vs. CT, p = 6.15 × 10−3; CC vs. TT, p = 5.74 × 10−5; CT vs. TT = 1.02 × 10−1).

References

    1. Bettiol A, Prisco D, Emmi G. Behcet: the syndrome. Rheumatology (Oxford). 2020;59(Supplement_3):iii101–iii7. - PubMed
    1. Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR. Behcet’s disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens. 1999;54(3):213–20. - PubMed
    1. Kilian NC, Sawalha AH. Behcet’s disease in the United States: A single center descriptive and comparative study. Eur J Rheumatol. 2017;4(4):239–44. - PMC - PubMed
    1. Mumcu G, Direskeneli H. Triggering agents and microbiome as environmental factors on Behcet’s syndrome. Intern Emerg Med. 2019;14(5):653–60. - PubMed
    1. de Menthon M, Lavalley MP, Maldini C, Guillevin L, Mahr A. HLA-B51/B5 and the risk of Behcet’s disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum. 2009;61(10):1287–96. - PMC - PubMed

Publication types

MeSH terms